Show/Hide Menu
Hide/Show Apps
Logout
Türkçe
Türkçe
Search
Search
Login
Login
OpenMETU
OpenMETU
About
About
Open Science Policy
Open Science Policy
Communities & Collections
Communities & Collections
Help
Help
Frequently Asked Questions
Frequently Asked Questions
Guides
Guides
Thesis submission
Thesis submission
MS without thesis term project submission
MS without thesis term project submission
Publication submission with DOI
Publication submission with DOI
Publication submission
Publication submission
Supporting Information
Supporting Information
General Information
General Information
Copyright, Embargo and License
Copyright, Embargo and License
Contact us
Contact us
Isoniazid Linked to Sulfonate Esters via Hydrazone Functionality: Design, Synthesis, and Evaluation of Antitubercular Activity
Date
2022-10-01
Author
KOÇAK ASLAN, EBRU
HAN, MUHAMMED İHSAN
Krishna, Vagolu Siva
Tamhaev, Rasoul
Dengiz, Çağatay
DOĞAN, ŞENGÜL DİLEM
Lherbet, Christian
Mourey, Lionel
Tonjum, Tone
GÜNDÜZ, MİYASE GÖZDE
Metadata
Show full item record
This work is licensed under a
Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License
.
Item Usage Stats
60
views
0
downloads
Cite This
Isoniazid (INH) is one of the key molecules employed in the treatment of tuberculosis (TB), the most deadly infectious disease worldwide. However, the efficacy of this cornerstone drug has seriously decreased due to emerging INH-resistant strains of Mycobacterium tuberculosis (Mtb). In the present study, we aimed to chemically tailor INH to overcome this resistance. We obtained thirteen novel compounds by linking INH to in-house synthesized sulfonate esters via a hydrazone bridge (SIH1-SIH13). Following structural characterization by FTIR, H-1 NMR, C-13 NMR, and HRMS, all compounds were screened for their antitubercular activity against Mtb H37Rv strain and INH-resistant clinical isolates carrying katG and inhA mutations. Additionally, the cytotoxic effects of SIH1-SIH13 were assessed on three different healthy host cell lines; HEK293, IMR-90, and BEAS-2B. Based on the obtained data, the synthesized compounds appeared as attractive antimycobacterial drug candidates with low cytotoxicity. Moreover, the stability of the hydrazone moiety in the chemical structure of the final compounds was confirmed by using UV/Vis spectroscopy in both aqueous medium and DMSO. Subsequently, the compounds were tested for their inhibitory activities against enoyl acyl carrier protein reductase (InhA), the primary target enzyme of INH. Although most of the synthesized compounds are hosted by the InhA binding pocket, SIH1-SIH13 do not primarily show their antitubercular activities by direct InhA inhibition. Finally, in silico determination of important physicochemical parameters of the molecules showed that SIH1-SIH13 adhered to Lipinski's rule of five. Overall, our study revealed a new strategy for modifying INH to cope with the emerging drug-resistant strains of Mtb.
Subject Keywords
antimycobacterial
,
Mycobacterium tuberculosis
,
drug-resistant clinical isolates
,
molecular modeling
,
InhA
,
MYCOBACTERIUM-TUBERCULOSIS
,
N-ACETYLTRANSFERASE
,
INHA INHIBITORS
,
DRUG
,
LIGANDS
,
AGENTS
,
TOOL
URI
https://hdl.handle.net/11511/100459
Journal
PHARMACEUTICALS
DOI
https://doi.org/10.3390/ph15101301
Collections
Department of Chemistry, Article
Suggestions
OpenMETU
Core
Proteomic Analysis of a hom-Disrupted, Cephamycin C Overproducing Streptomyces clavuligerus
Unsaldi, Eser; KURT KIZILDOĞAN, ASLIHAN; ÖZCAN, SERVET; Becher, Dorte; Voigt, Birgit; Aktas, Caner; Özcengiz, Gülay (2021-01-01)
Background: Streptomyces clavuligerus is prolific producer of cephamycin C, a medically important antibiotic. In our former study, cephamycin C titer was 2-fold improved by disrupting homoserine dehydrogenase (hom) gene of aspartate pahway in Streptomyces clavuligerus NR-RL 3585.
Sex-biased Expression of Neuroimmune Guidance Cues in Cardiovascular Diseases
Marouf , Yacine; Dogan, S. Onur; Benavente, Ernest Diez; Ruijter, Hester M. den; vanGils, Janine; Rayner, Katey; Kazan, Hilal (Orta Doğu Teknik Üniversitesi Enformatik Enstitüsü; 2022-10)
Atherosclerotic vascular disease continues to be a leader of morbidity and mortality. Although sex hormones are known to play a role in this lipid-and inflammatory-driven disease, the underlying mechanisms are largely unclear. Neuroimmune guidance cues (NGCs) are key regulators of cell movement and positioning, and have emerged as significant players in inflammation.Here, we analyze several gene expression datasets from human atherosclerotic plaques as well as normal, IFNγ-exposed human induced plu...
Studies directed towards The synthesis Of İmatinib Mesylate ((Gleevec), 4-(4-Methyl-Piperazin-1- Ylmethyl)-N-[4- Methyl-3-(4-Pyridin-3-Yl-Pyrimidin-2- Ylamino)-Phenyl]- Benzamide Methanesulfonate) Analogs
Günay, Neşet Batuhan; Demir, Ayhan Sıtkı; Department of Chemistry (2008)
Imatinib mesylate is indicated for the treatment of chronic myeloid leukemia (CML) and unresectable and/or metastatic malignant gastrointestinal stromal tumors (GIST). By the application of this anticancer drug, problems occurs in terms of stability and activity. Computer assisted design (CAD) works showed that the modification of the B and C part molecule can increase the effectivity of the drug. The new derivatives of the drug will be obtained to change some part of the B and C segments. The total synthes...
Amifostine, a radioprotectant agent, protects rat brain tissue lipids against ionizing radiation induced damage: An FTIR microspectroscopic imaging study
Cakmak, Gulgun; Miller, Lisa M.; Zorlu, Faruk; Severcan, Feride (Elsevier BV, 2012-04-15)
Amifostine is the only approved radioprotective agent by FDA for reducing the damaging effects of radiation on healthy tissues. In this study, the protective effect of amifostine against the damaging effects of ionizing radiation on the white matter (WM) and grey matter (GM) regions of the rat brain were investigated at molecular level. Sprague-Dawley rats, which were administered amifostine or not, were whole-body irradiated at a single dose of 800 cGy, decapitated after 24 h and the brain tissues of these...
Synthesis of novel diflunisal hydrazide hydrazones as anti-hepatitis C virus agents and hepatocellular carcinoma inhibitors
ŞENKARDEŞ, SEVİL; Kaushik-Basu, Neerja; Durmaz, Irem; Manvar, Dinesh; Basu, Amartya; Atalay, Rengül; KÜÇÜKGÜZEL, ŞÜKRİYE GÜNİZ (2016-01-27)
Hepatitis C virus (HCV) infection is a main cause of chronic liver disease, leading to liver cirrhosis and hepatocellular carcinoma (HCC). The objective of our research was to develop effective agents against viral replication. We have previously identified the hydrazide hydrazone scaffold as a promising hepatitis C virus (HCV) and hepatocelluler inhibitor. Herein we describe the design a number of 2',4'-difluoro-4-hydroxy-N'-(arylmethylidene) biphenyl-3-carbohydrazide (3a-t) as anti-HCV and anticancer agen...
Citation Formats
IEEE
ACM
APA
CHICAGO
MLA
BibTeX
E. KOÇAK ASLAN et al., “Isoniazid Linked to Sulfonate Esters via Hydrazone Functionality: Design, Synthesis, and Evaluation of Antitubercular Activity,”
PHARMACEUTICALS
, vol. 15, no. 10, pp. 0–0, 2022, Accessed: 00, 2022. [Online]. Available: https://hdl.handle.net/11511/100459.